DawaDose, a startup specializing in digital solutions for the pharmaceutical sector, has successfully closed its pre-seed funding round with a group of angel investors. The company also announced that it is officially establishing its headquarters in Saudi Arabia, which will serve as a launchpad for its operations in the Kingdom and its future expansion across the GCC.
By The Numbers
- Funding Round: Pre-Seed
- Investors: Angel Investors
- Headquarters: Saudi Arabia
- Sector: Pharma-Tech
Building a Digital Pharmaceutical Ecosystem
DawaDose is building an integrated digital platform designed to seamlessly and securely connect consumers with pharmacies and drug warehouses. The startup’s mission is to reshape pharmaceutical e-commerce in the region by creating a more efficient and accessible healthcare experience for everyone.
“This funding is not just capital, but a vote of confidence in our vision to digitally transform access to healthcare in the Middle East, starting from Saudi Arabia,” said Rushdi Abdelghani, Co-founder and CEO of DawaDose.
A Saudi Launchpad for Regional Ambition
The strategic decision to establish its headquarters in Saudi Arabia positions DawaDose to capitalize on the Kingdom’s rapid digital transformation in the healthcare sector. The move aligns directly with the goals of Saudi Vision 2030 to foster innovation and promote smart health services.
“We are building DawaDose as a Saudi company with a global vision, and this is just the beginning of reshaping pharmaceutical e-commerce in the region,” explained Osama Al-Mabroum, Co-founder and Business Development Manager.
About DawaDose
DawaDose is a pharma-tech startup building a digital ecosystem to connect consumers, pharmacies, and drug warehouses. The platform aims to provide a secure, seamless, and efficient e-commerce experience for pharmaceutical products and services.
Looking Ahead
With fresh pre-seed funding and a strategic base in the region’s largest market, DawaDose is well-positioned to tackle the burgeoning digital pharmacy space. The company’s next phase will focus on scaling its operations within Saudi Arabia before expanding into other GCC markets, contributing to the broader trend of digital innovation in the Kingdom’s healthcare sector.
Source: Jawlah
